MERGERS AND ACQUISITIONSHow Novartis Drug Approval Makes Biosimilar Makers Ripe for AcquisitionBy Laura CooperMar 31, 2015 9:13 AM EDT
OPINIONSo Far in 2015, This Choppy Market Is for Stock-Picker's OnlyBy Paul ScolardiJan 28, 2015 1:55 PM EST
OPINIONHow to Invest in the New Industry of 'Biosimilar' or 'Generic' Biological DrugsBy Paul ScolardiJan 9, 2015 12:57 PM EST
INVESTING5 Stocks Under $10 Setting Up to Trade Higher: Callon Petroleum and MoreBy Roberto PedoneJan 9, 2015 10:32 AM EST
INVESTINGYahoo! and eBay Climb After Resuming Merger Talks; IPOs Get Mixed ResultsBy Eileen KinsellaMar 24, 2000 6:43 PM EST
MARKETSMidday Movers: Eidos, Wit Capital, ePrise and AmeritradeBy Eileen KinsellaMar 24, 2000 1:32 PM EST
